Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of Activated T-lymphocyte ("Immuncell-LC") Cell Therapy in Gemcitabine Refractory Advanced Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2017
At a glance
- Drugs T-lymphocyte cell therapy (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 23 Jun 2013 New source identified and integrated (ClinicalTrials.gov; NCT00965718).
- 04 Jul 2011 New trial record
- 29 Jun 2011 Results from 16 patients were reported at the Spring Conference of the Korean Pancreatobiliary Association.